Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FP-DTBZ PET Imaging for Beta Cell Mass
NCT02236754Phase 1Completed
- Sponsor
- Columbia University
- Start
- Jul 2013
- Primary completion
- Apr 2014
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by Columbia University. Primary endpoint: Mean VMAT2 Functional Binding Capacity in the Beta Cells to 18 F-FP-DTBZ up to 2 months. Started Jul 2013; status: completed.
Beyond the preview
Go deeper on NCT02236754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02236754.